Bud BilanichSuccess Coach
Paul TheisenPatient Acquisition
Liz KaneImpactful Strategy
David LinetskyPoint-of-Care Marketing
Suma Ramadas, PhDMedical Affairs
Matthew DurhamOmnidynamic Marketing
Brenda SnowAuthentic Patient Voice
Daniel SontupeMarket Access
Frank BurrellScientific Storytelling
Pat PurcellMeeting Engagement
Joey CohenMedication Adherence
Amy GilesIncreasing Engagement
Stacey GandlerBrand Nourishment
Matt TurnerPatient Affordability
MEDFORD, N.Y., May 09, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader ...
On Track to Resubmit NDA for lutetium Lu 177 dotatate (Lutathera®) to FDA in ...
- PD-1治療抵抗性の皮膚メラノーマの3人の患者に奏効し、そのうちの1人では完全奏効 (CR) を実現 - - IMO-2125の臨床開発の優先度が高くなったため、同社はB細胞リンパ腫治療のためのIMO-8400の開発を一時中止 - セッツ州ケンブリッジおよびペンシルベニア州エクストン, Sept. 27, 2016 (GLOBE NEWSWIRE) ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email